SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001085037-23-000091
Filing Date
2023-08-17
Accepted
2023-08-17 11:22:53
Documents
8
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K f6k081723.htm 6-K 8037
2 EXHIBIT 99.1 - NOTICE OF MEETING AND RECORD DATE ex99_1.htm EX-99.1 6342
3 EXHIBIT 99.2 - NEWS RELEASE ex99_2.htm EX-99.2 8831
4 EXHIBIT 99.3 - MATERIAL CHANGE REPORT ex99_3.htm EX-99.3 5342
5 EXHIBIT 99.4 - NEWS RELEASE ex99_4.htm EX-99.4 9596
6 image0.jpg GRAPHIC 2021
7 image00002.jpg GRAPHIC 4679
8 image00003.jpg GRAPHIC 2545
  Complete submission text file 0001085037-23-000091.txt   52566
Mailing Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1
Business Address SUITE 900 - 570 GRANVILLE STREET VANCOUVER BC A1 V6C 3P1 604-248-8693
REPLICEL LIFE SCIENCES INC. (Filer) CIK: 0001205059 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-50112 | Film No.: 231180466
SIC: 2836 Biological Products, (No Diagnostic Substances)